New advances, discoveries and understanding of disease is resulting in improved diagnosis, treatment and outcomes for people across the world. Working from our state-of-the-art facilities in Europe, our team provides an essential support role to life scientists at the leading edge of clinical and pharmaceutical research and development. We have developed a range of small-scale organic molecules, intermediates and syntheses to support pharmaceutical, biotechnology, academic and private researchers in their breakthroughs, discoveries and innovations.

Researchers rely on our small-scale organic molecules and compounds, including active ingredients for dietary supplements, to use as reagents or intermediates in organic synthesis reactions. We have also developed a range of highly potent and oncology APIs for use in oncological research and development.